Dosage Forms & Drug Delivery Systems – Page 20

Assay Oos during bulk hold: GMP investigation and CAPA strategy

Symptoms or signals indicating possible issues with the assay during bulk hold can emerge from various sources within the manufacturing process. Observations may include:Click to read the full article.

Dropper Compatibility Failure during aseptic filling: sampling, filtration, and EM controls

Dropper compatibility failures can manifest through various symptoms that signal potential issues during the aseptic filling process. Key observations may include:Click to read the full article.

Assay Oos after excipient change: packaging compatibility and stability justification

The identification of symptoms indicating a potential OOS scenario is the first step in any investigation. Symptoms may manifest in various ways, including:Click to read the full article.

Emulsion Inversion during bulk hold: cleaning validation and worst-case selection

Identifying the symptoms of emulsion inversion is the first step in any investigative process. Common signals that may indicate a problem include:Click to read the full article.

Ccit Failure after packaging change: how to avoid repeat 483 observations

The initial step in addressing a CCIT failure is recognizing the symptoms or signals that indicate a deviation has occurred. These may manifest as:Click to read the full article.

Tube Leakage Complaint after excipient change: packaging compatibility and stability justification

The first step in responding to a tube leakage complaint is recognizing the symptoms. Signals may arise from several sources:Click to read the full article.

Ph Drift during method transfer: complaint trending and risk-based actions

Identifying signals of pH drift during method transfer is the first step in any investigation. Common symptoms may include:Click to read the full article.

Dropper Compatibility Failure during aseptic filling: FDA-ready investigation report and batch disposition

Identifying symptoms that indicate a dropper compatibility failure is the first step in an effective investigation. Common signs include:Click to read the full article.

Assay Oos during bulk hold: packaging compatibility and stability justification

Symptoms of assay OOS during bulk hold phases may manifest in various ways, starting with the detection of unexpected results during routine testing. Specific signals may include:Click to read the…

Edge Lifting during lamination: process parameter review and validation impact

Edge lifting during lamination can manifest through various signals that should immediately alert manufacturing and quality control teams. Common symptoms include:Click to read the full article.

Tube Leakage Complaint in cream manufacturing: packaging compatibility and stability justification

The first step in addressing tube leakage complaints is to identify specific symptoms that signal a problem. Symptoms can originate during various stages of the production process, storage, or even…

Ph Drift in eye drop manufacturing: packaging integrity and CCIT justification

Identifying the symptoms associated with pH drift is critical in early detection and remediation. Common signals include:Click to read the full article.